Primary VHH Nanobodies

Primary VHH Nanobodies from ChromoTek, available through Mason Technology, offer researchers an innovative alternative to conventional primary antibodies for protein detection and imaging. Developed using recombinant camelid single-domain antibody technology, these nanobodies combine exceptional specificity with a molecular size significantly smaller than traditional IgG antibodies. The result is improved tissue penetration, enhanced imaging resolution and highly reproducible performance across a broad range of research applications.

Their compact structure allows Primary VHH Nanobodies to bind epitopes that may be difficult for larger antibodies to access. This makes them particularly valuable for super-resolution microscopy, immunofluorescence, immunohistochemistry and protein localisation studies, where reducing the distance between the target protein and fluorescent label improves image accuracy.

Produced recombinantly under tightly controlled conditions, Primary VHH Nanobodies deliver excellent batch-to-batch consistency and eliminate the variability associated with hybridoma-derived antibodies. Researchers also benefit from lower background staining and improved signal-to-noise ratios, resulting in clearer experimental data and more reliable interpretation.

Primary VHH Nanobodies Key Features

• Recombinant alpaca-derived VHH nanobodies.
• Significantly smaller than conventional IgG antibodies.
• High affinity and excellent target specificity.
• Improved tissue penetration and epitope accessibility.
• Reduced background staining.
• Ideal for immunofluorescence and super-resolution microscopy.
• Excellent batch-to-batch consistency.
• Recombinant production for reliable reproducibility.
• Suitable for multiple protein detection applications.
• Supported by Mason Technology.

Primary VHH Nanobodies provide researchers with a modern approach to protein detection by combining high specificity with the unique advantages of recombinant nanobody technology. Their ability to generate high-resolution images and reproducible staining makes them particularly valuable in cell biology, neuroscience and structural biology research.

As Proteintech’s trusted partner in Ireland, Mason Technology provides access to the complete ChromoTek Primary VHH portfolio together with expert technical guidance and responsive customer support.

Finding the right products for your research can be overwhelming. Proteintech’s new AI powered search tool, ‘Able’, makes the process easier and faster.